Findings show benefits compared with FOLFIRI for patients with untreated metastatic colorectal cancer disease.
Most cancer patients use lifestyle-altering strategies and about 40 percent adopt care-altering strategy.
Top reasons for gastrointestinal cancer hospitalization include electrolyte disorders, intestinal obstruction, pneumonia.
Patients with bladder cancer who did not receive an optimal biopsy were more likely to die from their disease.
Researchers identified potential new targets for personalized cancer vaccines.
Findings among older patients with terminal ovarian cancer receiving hospice care.
Boehringer has enrolled the first in a global phase 3 trial investigating nintedanib in metastatic colorectal cancer.
Researchers have found that dacomitinib was not superior to erlotinib in patients with advanced non-small cell lung cancer (NSCLC).
Addition of trastuzumab (Herceptin) to chemo for breast cancer improves survival.
Abiraterone significantly improves progression-free survival in metastatic castration-resistant prostate cancer (mCRPC).
Markers successfully detected prostate cancer in patient urine samples and up-regulated versus normal urine.
Findings in comparative economic analysis of patients with node-negative breast cancer.
Administering copper and a drug that kills copper-containing cells in prostate cancer.
Dacomitinib was not effective at improving overall survival in advanced non-small cell lung cancer (NSCLC).
For some men, prostate cancer recurrence may be overdetected, especially in those aged over 70.
Health sector prices explain much of difference between U.S. and other high-spending countries.
Millions signing up for Medicaid to comply with federal health care law.
Almost 80% of doctors in the United States have switched from paper to electronic health records.
Most physicians believe that doctors order too many medical tests, yet half admit to doing so themselves in response to a patient who insists, a new survey shows.
Several modifiable risk factors can cut chronic disease deaths over the next 15 years.
Caucasian women overestimate their risk of breast cancer while African American and Hispanic women underestimate their risk, according to research presented at BCS 2013.
A survey presented at BCS 2013 has found a number of factors that cause rural US women to avoid breast cancer screening.
The benefit of perioperative MRI for women with ductal carcinoma in situ (DCIS) is "uncertain," found a study presented during BCS 2013.
ChemotherapyAdvisor.com Editorial Board member Dr. Edith Perez of the Mayo Clinic, Jacksonville, FL, recommends high impact abstracts at the Breast Cancer Symposium 2013.
Women who underwent radiation for ductal carcinoma in situ do not face an increased risk of cardiovascular disease, found a study presented at BCS 2013.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|